Endothelial cells expressing ®broblast growth factor receptor-1 (FGFR-1) migrate and proliferate in response to treatment with FGF. We analysed ligand-induced migration and proliferation of porcine aortic endothelial cells expressing wild-type FGFR-1, point-mutated Y766F FGFR-1, unable to activate phospholipase C-g1 (PLCg1), or carboxyl-terminally truncated FGFR-1, lacking either 48 (from amino acid 774 in the FGFR-1 sequence) or 63 (from amino acid 759) amino acid residues of the C-terminal tail. The truncated CT63 FGFR-1 mutant failed to mediate chemotaxis, but was in response to ligand stimulation capable of mediating proliferation of the cells, stimulation of MAP kinase activity and tyrosine phosphorylation of FRS2, an FGFR-1 speci®c signaling molecule. The defect in migration-capacity of CT63 was not due to loss of Y766, and thereby PLC-g1 activation, since cells expressing the mutant Y766F FGFR-1 migrated as eciently as the wild-type receptor cells. Induction of phospholipase A 2 (PLA 2 ) activity by the activated FGFR-1 was dependent on the presence of Y766, and was therefore also not critical for the chemotactic response. Although the FGFR-1 only very ineciently mediates activation of phosphatidylinositol 3' kinase (PI 3-kinase), the PI 3-kinase inhibitor wortmannin suppressed wild-type FGFR-1 mediated migration. We conclude that the signal transduction pathway for FGFR-1 mediated migration is independent of phosphotyrosine residues in the receptor and requires activation of a wortmannin-sensitive enzyme.
Introduction
Growth factors mediate their biological eects by binding to and activating receptors with tyrosine kinase activity, leading to series of molecular events which ultimately are manifested as biological responses such as changes in migration, proliferation, differentiation and metabolism (Ullrich and Schlessinger, 1990) . Thus, binding of the growth factor induces receptor dimerization followed by activation of the kinase and autophosphorylation, which creates binding sites for signal transduction molecules with enzymatic activity such as phospholipase C-g (PLC-g), phosphatidylinositol 3' kinse (PI 3-kinase) and Ras GTPase activating protein (rasGAP), or lacking enzymatic activity (adaptor molecules) such as Shc and Grb2. These proteins bind to tyrosine phosphorylation sites in the receptor cytoplasmic domain through their Src homology 2 (SH2) domains. In conjunction with receptor binding, there is a change in the intrinsic or indirectly associated activities of the signal transduction molecules, creating signaling chains. Activation of dierent signal transduction molecules is believed to initiate distinct signaling chains, each giving rise to unique responses. For example, binding of Grb2 to the activated epidermal growth factor receptor or plateletderived growth factor (PDGF) receptor initiates the Ras-dependent MAP kinase pathway which is believed to be the major pathway for mitogenicity Egan et al., 1993) whereas activation of PI 3-kinase is involved in chemotactic signaling by the PDGF b-receptor .
The ®broblast growth factor receptor-1 (FGFR-1) is a receptor tyrosine kinase expressed in a wide variety of cell types, predominantly in the brain and mesenchymal tissues (for reviews see Jaye et al., 1992; Johnson and Williams, 1993) . Several members of the ®broblast growth factor family of which FGF-1 (aFGF) and FGF-2 (bFGF) are the best characterized bind to the FGFR-1 with high anity. In vivo, FGF-1 and FGF-2 act as angiogenic factors (Folkman, 1995) and as potent inducers of DNA synthesis. In vitro, FGF-1 stimulates endothelial cell migration and proliferation (reviewed by Burgess and Maciag, 1989) . Activation of FGFR-1 by FGFs induces both mitogenic (Shaoul et al., 1995; Wang et al., 1994) and chemotactic (Clyman et al., 1994) responses in various cell types but very little is known about the signaling pathways used in these processes. Seven autophosphorylation sites in FGFR-1 have been identi®ed . Only one of them has been shown to directly bind an SH2 domain molecule; PLC-g associates with the activated FGFR-1 via phosphorylated tyrosine 766 (Mohammadi et al., 1991) and becomes tyrosine phosphorylated and activated, leading to hydrolysis of phosphatidylinositol 4,5 bisphosphate (PIP 2 ). The biological consequences of this activation are not completely understood. The Y766F mutant FGFR-1 in which tyrosine 766 is replaced by a phenylalanine residue, internalizes at a reduced rate (Sorokin et al., 1994) and causes a reduced MAP kinase activation (Huang et al., 1995) , but is both mitogenically and chemotactically competent (Clyman et al., 1994; Mohammadi et al., 1992; Peters et al., 1992) . Activation of PLC-g is also not critical for induction of urokinase type plasminogen activator (uPa; Roghani et al., 1996) . It is well established that FGFR-1 activation leads to phosphorylation of Shc and activation of Raf-1 and MAPK (Klint et al., 1995; Shaoul et al., 1995; Wang et al., 1994) whereas other signal transduction molecules which have been implicated in chemotactic signaling i.e. PI 3-kinase and rasGAP do not bind to or become activated by FGFR-1 (Molloy et al., 1989; WennstroÈ m et al., 1992) .
In this paper, we describe an FGFR-1 mutant in which 63 amino acids in the COOH terminal tail are deleted and which is enzymatically and mitogenically active but has lost its ability to transduce migratory signals. We present evidence for a wortmanninsensitive FGFR-1 signal transduction pathway which is independent of phosphotyrosine residues in the receptor.
Results

Characterization of wild-type and mutant chimeric receptors
We have previously described porcine aortic endothelial (PAE) cell lines expressing FGFR-1 mutants in which the tyrosine residues outside the kinase domain individually were replaced by phenylalanine residues (Landgren et al., 1995) . In dierent assays for biological activity, these cell lines have responded to FGF-stimulation in a manner indistinguishable from PAE cells expressing wild type FGFR-1. Therefore, in order to de®ne the structural requirement for FGFinduced migration, FGFR-1 deletion mutants were constructed. As seen in the schematic outline ( Figure  1a) , the mutants were truncated in their carboxyl terminus either below (CT48) or above (CT63) of tyrosine residue 766. For comparison, a mutant containing a phenylalanine residue instead of a tyrosine residue at position 766 was created (Y766F). To avoid interference from endogenously expressed FGF receptors, the receptor constructs were designed as chimeric receptors consisting of the extracellular and transmembrane domains of platelet-derived growth factor (PDGF) a-receptor fused to the intracellular domain of FGFR-1. The cDNA's encoding the dierent chimeric receptors were stably introduced into PAE cells which lack endogenous PDGF receptor expression.
To ensure that the dierent receptor constructs were expressed at similar levels and able to autophosphorylate, immunoblotting analysis was performed. PAE cells expressing aR/FR:wt, aR/FR:Y766F, aR/ FR:CT48 or aR/FR:CT63 were stimulated or not with PDGF-BB for 7 min at 378C and after lysis of the cells, immunoprecipitations were performed with antibodies recognizing the juxtamembrane part of FGFR-1. The immunoprecipitates were separated by SDS ± PAGE and transferred to nitrocellulose membrane. The ®lter was blotted with phosphotyrosine antibody (Figure 1c ) and after stripping of the ®lter, with receptor antibody (Figure 1d ). The amount of receptor proteins and their Figure 1 (a) Schematic illustration of PDGF a-receptor/FGFR-1 chimeric constructs. The extracellular domain from the PDGF a-receptor contains ®ve immunoglobulin-like domains (circles). The intracellular domains from the wild-type (wt) FGFR-1 or the point-mutated (Y766F) FGFR-1 or the deletion mutants, CT48 (lacking 48 amino acid residues of the C-terminal tail) and CT63 (lacking 63 amino acid residues), were fused to the PDGF areceptor transmembrane and extracellular domains. The ®rst (TK 1) and second (TK 2) parts of the tyrosine kinase domain and the kinase insert (KI) are indicated. (b) The amino acid sequence of the 15 amino acid residues that distinguish CT48 from CT63. (c and d) Ligand stimulation of the dierent chimeric receptors expressed in PAE cells. After treatment of the cells with (+) or without (7) PDGF-BB (100 ng/ml) for 7 min at 378C, the cells were lysed and immunoprecipitated (ip) with antibodies against FGFR-1. Immunoprecipitated samples were subjected to SDS ± PAGE, transferred to nitrocellulose ®lters which were incubated (ib) with phosphotyrosine antibody (c) or receptor antibody (d). The migration positions of the receptors are indicated, as well as migration positions of marker proteins (myosin, 200 kDa; phosphorylase b, 97 kDa) run in parallel abilities to autophosphorylate appeared similar between the dierent cell lines.
PAE cells expressing the CT63 mutant fail to migrate
By use of a modi®ed Boyden chamber, ligand-induced cell motility responses were determined for cells expressing the chimeric receptors. PAE cells expressing aR/FR:wt, aR/FR:Y766F, aR/FR:CT48 or two independent clones of cells expressing aR/FR:CT63 were suspended in serum-free Ham's F12 medium and placed above a 8 mm-thick nitrocellulose ®lter. PDGF-BB (50 ng/ml) in serum-free Ham's F12 medium was added on the opposite side of the ®lter. As a control, 10% fetal bovine serum (FBS) was used as a chemoattractant. After 4 h incubation at 378C, the ®lters were ®xed and stained, and the number of cells which had moved through the ®lter was counted. As seen in Figure 2 , ligand-induced chemotaxis was markedly reduced in both cell lines expressing aR/ FR:CT63 in comparison to the responses seen for the other cell lines. The response upon FBS-stimulation was similar in all the cell lines including the cells expressing aR/FR:CT63. In total, six independent clones of PAE cell expressing aR/FR:CT63 were examined and all showed a considerable decreased capacity to migrate upon ligand-stimulation.
The truncated receptors mediate stimulation of cell proliferation and MAPK activity
We next examined whether there were any dierences between ligand-stimulated wild-type and mutant receptors in their abilities to mediate proliferation. Cell proliferation assays were performed at varying concentrations of ligand and increases in cell numbers were scored after 5 days (Figure 3a ). Over this time period, the CT48 mutant cell line transduced a mitogenic response to 20 ng/ml PDGF-BB with similar eciency as cells expressing the wild type receptor. Cells expressing either aR/FR:Y766F or aR/ FR:CT63 responded to 20 ng/ml PDGF-BB with similar and slightly lower eciencies, as compared to the wild-type receptor cells. This slight reduction in mitogenic capacity of FGFR-1 mutants lacking Y766 is in agreement with previous reports (Klint et al., 1995) .
We have previously shown that activation of FGFR-1 leads to tyrosine phosphorylation of an 89-kDa-component, FRS2 (Kouhara et al., 1997) . Tyrosine phosphorylated FRS2 binds the adaptor protein Grb2, which exists in a complex with the nucleotide exchange factor Sos and thereby regulates Ras activity (Klint et al., 1995) . Regulation of Ras activity and subsequent changes in MAP kinase activity is believed to be of importance in mitogenic signaling by receptor tyrosine kinases. Therefore the complex formation of p89/FRS2 and Grb2 after activation of PAE cells expressing aR/FR:wt, aR/ FR:Y766F, aR/FR:CT48 or aR/FR:CT63 was studied ( Figure 3b ). Cells were treated with or without PDGF for 8 min at 378C and then lysed. Lysates were incubated with puri®ed immobilized GST-Grb2 SH2 domain fusion protein for 2 h at 48C. The samples were washed and separated by SDS ± PAGE and transferred to nitrocelluose membrane. The ®lter was blotted with phosphotyrosine antibody. The wild-type and mutant receptors showed similar abilities to induce complex formation of p89/FRS2 with the Grb2 SH2 domain.
We then investigated whether stimulation of the wild-type and mutant receptors leads to an increase in activity of the MAP kinase Erk2. PAE cells expressing aR/FR:wt, aR/FR:Y766F, aR/FR:CT48 or aR/FR:CT63 were treated with PDGF (100 ng/ml) for 5 min at 378C. The cells were lysed and Erk2 was immunoprecipitated and subjected to a kinase reaction in the presence of myelin basic protein (MBP) which served as an exogenous substrate. Incorporation of 32 P-radioactivity into MBP was analysed through subsequent SDS ± PAGE and autoradiography and was taken as a measure of Erk2 activity. Figure 3c shows that stimulation of cells expressing the wild-type receptor induced activation of Erk2 to an extent similar to that seen in stimulated mutant receptor cell-lines. Since the mutant receptor aR/FR:CT63 was able to mediate mitogenic signals, we concluded that there was no general impairment of the receptor function but that it had lost a speci®c signaling capacity which is dependent on amino acids residues 759 ± 773 in the COOH-terminal tail and which is necessary for FGFR-1 mediated chemotaxis.
The truncated receptor aR/FR:CT63 fails to mediate phosphorylation of PLC-g Several SH2 domain-containing proteins such as PI3-K, rasGAP and PLC-g have been implicated in transduction of the chemotactic response elicited by receptor tyrosine kinases. Among these, PLC-g has been identi®ed as a substrate for FGFR-1. In order to understand which signal transduction pathway that was impaired in the truncated receptor aR/FR:CT63, we analysed the eciency with which PLC-g was tyrosine phosphorylated in PAE cells expressing wild type aR/FR or truncated aR/FR (Figure 4a and b) . As expected, PDGF-BB stimulated the receptor association and tyrosine phosphorylation of PLC-g in PAE cells expressing either aR/FR:wt or aR/FR:CT48. In contrast, there was no ligand-stimulated receptor association and tyrosine phosphorylation of PLC-g in cells expressing aR/FR:CT63, in accordance with the notion that Y766 serves as a binding site for PLC-g.
Phosphorylation of PLC-g has been reported to enhance its catalytic activity, resulting in elevated levels of inositol phosphates. To further rule out a role for PLC-g in FGFR-1-mediated chemotaxis, we examined the eects of ligand stimulation on inositol phosphate turnover in PAE cells expressing aR/FR:wt, aR/ FR:Y766F, aR/FR:CT48 or aR/FR:CT63. As shown in Figure 4c , both cells expressing aR/FR:Y766F and cells expressing aR/FR:CT63 failed to increase the rate of inositol phosphate turnover. Since aR/FR:Y766F is chemotactically competent, it is not likely that production of inositol phosphates is critical for the FGFR-1 mediated chemotactic response.
Stimulation of arachidonic acid release is dependent of Tyr 766
It has been suggested that FGF-stimulated endothelial cell movement is mediated by activation of PLA 2 via a pertussis toxin-sensitive pathway (Sa and Fox, 1994) . (7) with 100 ng/ml of PDGF-BB, lysed and immunoprecipitated (ip) with antiserum against PLC-g. The samples were separated by SDS ± PAGE, transferred to nitrocellulose ®lters and immunoblotted (ib) with (a) phosphotyrosine antibody or (b) antiserum against PLC-g. (c) Cells were incubated with myo[ 3 H]inositol for 24 h followed by lithium chloride incubation for 15 min at 378C. Cells were then treated with (hatched bars) or without (®lled bars) PDGF-BB (100 ng/ml) for 10 min at 378C and lysed with acidi®ed methanol. The measurement of inositol phosphate formation was carried out as described under Materials and methods and quanti®ed by liquid scintillation counting
We examined the role of PLA 2 in our cell model by measuring of the release of arachidonic acid in PDGFstimulated PAE cells. Cells were incubated with serumfree medium containing [ 3 H]arachidonic acid for 20 h and then washed twice with serum-free medium followed by PDGF stimulation (50 ng/ml) for 20 min at 378C to activate the wild-type and mutant aR/FR expressing cells. The conditioned media were collected and 3 H-radioactivity was determined by scintillation counting. Figure 5 shows that activation of aR/FR:wt leads to a twofold increase in arachidonic acid release. However, this increase in arachidonic acid release is close to abolished in PDGF-stimulated cells expressing aR/FR:Y766F or aR/FR:CT63 in support of a role for Tyr 766 in the activation of PLA 2 . The failure of aR/ FR:Y766F to mediate arachidonic acid release while still being an ecient transducer of migration, indicates that PLA 2 activity is not critical for FGFR-1 mediated motility in this cell type.
Wortmannin inhibits FGFR-1 mediated chemotaxis
Signal transduction leading to chemotaxis via the PDGF-b receptor has been shown to be dependent on PI 3-kinase activtion. To examine whether PI 3-kinase is involved in FGFR-1 mediated chemotaxis, two independent clones of PAE cells expressing aR/ FR:wt were analysed for ligand-or FBS-induced cell motility in the presence or absence or 100 nM of the PI 3-kinase inhibitor wortmannin. As see in Figure 6 , the presence of wortmannin eliminated the ligand-induced cell motility response, but caused only a weak reduction of the FBS-induced response. This result implicates PI 3-kinase in the chemotactic signaling by FGFR-1. Under the same conditions, the PI 3-kinase inhibitor LY294002 (2.8 mM) also inhibited FGFR-1 mediated chemotaxis (data not shown).
Discussion
Wound-healing, embryogenesis, and angiogenesis are examples of physiological processes which are dependent on chemotaxis of cells. It is known that many dierent growth factors stimulate cell migration. Signal transduction through the PDGF b-receptor leading to chemotaxis has been carefully dissected and shown to depend on activation on PI3-kinase as well as PLC-g (Kundra et al., 1994; RoÈ nnstrand et al., 1992; WennstroÈ m et al., 1994) . In this paper, we have studied chemotactic signaling via the FGFR-1, and identi®ed a stretch between amino acid residues 759 and 773, located immediately following the second kinase domain, as critical for FGFR-1-dependent migration. This stretch contains Y766, which is phosphorylated in the activated receptor and which serves as a binding site for PLC-g. Since a receptor equipped with the 759 ± 773 stretch, but lacking the PLC-g binding site (Y766F) still is chemotactically competent, there is however no indication for an involvement of PLC-g in the migratory response transduced via FGFR-1. This is in agreement with the fact that treatment of cells with the PKC inhibitor bisindolylmaleimide had no eect on wild-type FGFR-1 mediated chemotaxis (data not shown) and consistent with previous reports (Clyman et al., 1994) . In addition to Y766, the 759-773 stretch contains two serine residues, at positions 762 and 770. Tryptic digestion of in vivo 32 P-labelled aR/FR:wt, followed by twodimensional separation of the tryptic peptides and radiochemical sequencing failed to show phosphorylation at these residues (data not shown), neither before nor after ligand stimulation. Thus it is not likely that serine residues have a role in signal transduction leading to migration.
On the other hand, our data do implicate PI3-kinase activity as critical for migration via FGFR-1, since wortmannin, known to eciently suppress PI3-kinase activity, attenuated FGFR-1-dependent migration in our assays. The 759 ± 773 stretch does not contain a binding site for PI3-kinase, and we have previously shown that PI3-kinase is only poorly, if at all, activated by FGFR-1 (Kanda et al., 1997) . It is therefore relevant to ask how wortmannin exerts its eects. There is a growing awareness that wortmannin inhibits also other types of enzymes apart from PI3-kinase. 3 H]arachidonic acid for 20 h followed by PDGF-BB stimulation for 20 min. The conditioned media were collected and the release of arachidonic acid was quanti®ed by liquid scintillation counting. The experiment was performed three times and the ®gure represents the mean+s.e.m. of triplicates from a representative experiment Figure 6 Wortmannin inhibits migration of PAE cells expressing aR/FR:wt. Cells were assayed for migration towards PDGF-BB (50 ng/ml) in the presence or the absence of 100 nM of wortmannin. Addition of 10% FBS as a chemoattractant, served as a control and data is presented as percentage of nonwortmannin treated FBS-stimulated cells. The results show mean+s.e.m of two independent clones in one experiment Elevated levels of phosphatidyl inositol 3,4,5 trisphosphate (PIP 3 ) is seen both as a result of activation of PI3-kinase, and of the G-protein-coupled p110g (Stoyanov et al., 1995) . It cannot be excluded that FGFR-1 communicates with G-protein-coupled signal transduction pathways to induce p110g activity, and that wortmannin in our model inhibits p110g and in consequence, cellular migration. In in vivo measurements of PIP 3 levels in FGF-2 stimulated L6 myoblasts expressing FGFR-1, we have however failed to record any increase in PIP 3 over a time period of 5 min (Kanda et al., 1997) . It has been suggested that wortmannin is a potent inhibitor also of G-protein activated PLA 2 (Cross et al., 1995) and possibly of other types of enzymes as well. This is noteworthy, since PLA 2 activity mediated by a pertussis toxinsensitive pathway has been implicated in FGF-2-induced migration/proliferation of bovine aortic endothelial cells (Sa and Fox, 1994) . Our data do not show any role for PLA 2 in migration, since the Y766F point mutant which was chemotactically active, had lost its capacity to mediate arachidonic acid release. There are important dierences between the assay systems, however. We used a Boyden chamber assay, counting the number of cells migrating during 4 h through a thin ®lter towards the chemoattractant, whereas Sa and Fox estimated the migration rate of cells in a`wounded' monolayer, during a 20 h incubation in the presence of growth factor. Furthermore, treatment of the PAE cells with pertussis toxin did not inhibit FGFR-1-mediated motility. In our hands pertussis toxin treatment rather potentiated the capacity of FGFR-1 to transduce migratory signals (data not shown), indicating a negative role for pertussis toxin-sensitive G-proteins in regulation of FGFR-1 mediated cellular migration. We are currently investigating this subject further.
A picture is thereby emerging with the wortmanninsensitive pathway as a regulator of the basic migration machinery. We do however lack formal evidence that the wortmannin-sensitive pathway originates from the 759 ± 773 stretch. Furthermore, we cannot prove that this stretch alone initiates the basic migration machinery; there could be yet another site outside of the 759 ± 773 stretch, potentially involving a phosphotyrosine residue, which participates in signal transduction leading to migration. It is possible that only when both sites are lost, as in aR/FR:CT63, there is a clear loss of migration. The carboxyl-terminal tail of FGFR-1 contains two tyrosine residues, at positions 766 and 776. Tyrosine 776 has not yet been examined regarding its phosphorylation status in the activated FGFR-1. We therefore labelled PAE cells expressing aR/FR:wt or aR/FR:Y766F with 32 P in vivo, followed by immunoprecipitation of aR/FR:wt and aT/FR:Y766F and trypsin digestion of the puri®ed receptor. The tryptic fragment containing Y766 as well as Y776 was immunoprecipitated using an antiserum speci®cally reacting with this region of the receptor. The immunoprecipitates were analysed through two-dimensional phosphoamino acid analysis for its content of phosphotyrosine. As seen in Figure 7 , there was no remaining phosphotyrosine in the tryptic fragment from the aR/FR:Y766F sample, indicating that Y776 is not a phosphorylation site. Our next assignment is therefore to continue dissecting the Y759-Y773 stretch, by making further discrete truncations of CT48, to identify the critical amino acid residues for FGFR-1 signal transduction regulating cellular migration.
Materials and methods
cDNA constructions
cDNA's for FGFR-1 (WennstroÈ m et al., 1991) and PDGFRa (Claesson-Welsh et al., 1989) were subcloned into the pAlter vectorTM (Promega Corporation) and site-directed mutagenesis was performed using the Altered Sites in vitro Mutagenesis system (Promega Corporation). Point mutations that created cleavage sites for HindIII at positions 1195 ± 1200 of the FGFR-1 and 1776 ± 1781 of the PDGFR-a were then introduced into the respective insert with oligonucleotides prepared using a Pharmacia LKB Gene Assemble Plus Synthesizer. The chimeric PDGFR-a/ FGFR-1 (denoted aR/FR) was constructed by cleaving the FGFR-1 and PDGFR-a cDNA's with HindIII and SalI followed by ligation of the fragment corresponding to the extracellular part of PDGFR-a to the fragment corresponding to the intracellular part of FGFR-1. Using the mutagenesis system described, a point mutation that changed tyrosine residue Tyr 766 to a phenylalanine residue was introduced into the cDNA for aR/FR. To make truncated receptors, point mutations were introduced creating stop codon and cleavage sites for XbaI at position 2278 ± 2284 or at position 2323 ± 2329 in the intracellular part of FGFR-1. These mutations resulted in substitutions of residue Ala 759 to a valine residue (CT63) and residue Asp 774 to a valine residue (CT48), respectively. All mutations and constructs were con®rmed by nucleotide sequencing. The wild type and the mutated cDNAs were inserted into the eukaryotic expression vector pcDNA3 (Invitrogen).
Cell culture and transfection
The porcine aortic endothelial (PAE; Miyazono et al., 1987) cell line was cultured in Ham's F12 medium (GIBCO BRL) supplemented with 10% fetal bovine serum (Sigma). The dierent cDNA's were introduced into PAE cell by electroporation, as described in Claesson-Welsh et al. (1988) . Selection of transfected cells was initiated after Figure 7 Two-dimensional phosphoamino acid analysis of trypsin-cleaved fragments derived from the carboxyl-terminal tail of wild-type or Y766F mutant receptors. PAE cells expressing aR/FR:wt or aR/FR:Y766F were labeled in vivo with 32 P-orthophosphate and stimulated with PDGF-BB (100 ng/ml) for 10 min at 378C. After stimulation, cells were washed, lysed and subjected to immunoprecipitation with anti-receptor antibodies. The immunoprecipitates were analysed by SDS ± PAGE and electrotransferred onto a nitrocellulose membrane. The bands corresponding to the receptors were cut out and cleaved with trypsin and immunoprecipitated with an antibody recognizing the carboxyl-terminal region of the FGF receptor. The immunoprecipitated tryptic peptides, corresponding to the region in the FGF receptor covering amino acid residues 757 ± 784, were hydrolyzed to allow phosphoamino acid analysis as described in Materials and methods 48 h by adding Geneticin (G418 sulfate, GIBCO BRL) at 0.4 mg/ml to the culture medium. Clones were picked after 2 weeks and examined for receptor expression by metabolic labeling of the cells with 35 S-methionine, lysis and immunoprecipitation. The expressions of aR/FR wild-type and mutant chimeric receptors were analysed by immunoprecipitation followed by immunoblotting. The wild-type and the dierent mutant chimeric receptors were expressed at comparable levels.
Ligand PDGF-BB was a kind gift from Carl-Henrik Heldin, Ludwig Institute for Cancer Research, Uppsala, Sweden.
Antisera, immunoprecipitation and immunoblotting
An FGFR-1 rabbit antiserum was raised against a fusion protein corresponding to the juxtamembrane domain of the human FGFR-1. The PLC-g antiserum was a kind gift from J Schlessinger, Department of Pharmacology New York University Medical Center. For immunoprecipitations, cells were grown in Ham's F12 containing 10% FBS, to 95% con¯uency in 75 cm 2 tissue culture¯asks. Cells were treated or not with PDGF-BB (100 ng/ml) for 7 min at 378C, rinsed once with ice-cold phosphate-buered saline (PBS) and then lysed in ice-cold Nonidet P 40 (NP 40) lysis buer (1% NP 40, 20 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 500 mM Na 3 VO 4 , 1% Aprotinin (Bayer), 1 mM phenylmethylsulfonyl¯uoride). Clari®ed supernatants were incubated with antiserum for 1 h at 48C, followed by incubation for 30 min with Immunosorb A (EC Diagnostics AB, Uppsala, Sweden). Immune complexes were collected by centrifugation and washed three times with lysis buer. Immunoprecipitates were denatured by boiling for 5 min in sample buer (4% SDS, 0.2 M Tris-HCl pH 8.8, 0.5 M sucrose, 5 mM EDTA, 0.01% bromophenol blue and 2% bmercaptoethanol), and resolved by SDS ± PAGE on 7% polyacrylamide gels. For immunoblotting, proteins were electrophoretically transferred onto nitrocellulose membranes (Hybond-C extra, Amersham), which were incubated with receptor antiserum, anti-phosphotyrosine antibody (PY 20, ICN Biochemicals), or PLC-g antiserum. The membranes were washed and then incubated with peroxidase-conjugated swine anti-rabbit immunoglobulins or peroxidase-conjugated sheep anti-mouse immunoglobulins (Amersham 1 : 1000 dilution). After washing, sites of antibody reactivity were visualized using the ECL Western blotting detection system (Amersham).
Chemotaxis assay
The assay was performed in a modi®ed Boyden chamber as described (Auerbach et al., 1991) using micropore nitrocellulose ®lters (8-mm-thick, 8-mm-pore) coated with type-1 collagen solution at 100 mg/ml (Vitrogen 100; Collagen Corporation). The cells were trypsinized and resuspended at a concentration of 1610 6 cells per ml in serum-free medium containing 0.2% BSA. The cell suspension was placed in the upper chamber and serumfree medium containing 0.2% BSA and 50 ng/ml PDGF-BB or medium containing 10% FBS, was placed below the ®lter in the lower chamber. After 4 h at 378C, the medium was removed and the cells sticking to the ®lter were ®xed in 99% ethanol and stained with Giemsa solution. The number of cells that had migrated through the ®lter was counted. All experiments were performed in triplicates.
Cell proliferation assay
Cells (3610 4 per well) were seeded into 24-well dishes. After 24 h, cells were incubated in Ham's F12 containing 0.3% FBS for another 24 h followed by incubation with or without PDGF-BB (1 and 10 ng/ml). Cells numbers were scored after 5 days. Medium was changed at days 2 and 4.
Grb2 SH2 fusion protein in vitro association
The SH2 domain of Grb2 was expressed as a GST fusion protein and was a kind gift of Dr J Schlessinger, New York University Medical Center, New York. The experiment was performed as described (Klint et al., 1995) . Brie¯y, transfected PAE cells were stimulated with 100 ng/ml PDGF-BB or left untreated for 8 min at 378C and then lysed in NP-40 lysis buer. Clari®ed lysates were incubated with puri®ed immobilized GST-Grb2 SH2 fusion protein on glutathione Sepharose 4B (Pharmacia) end over end for 2 h at 48C. Samples were washed twice in NP-40 lysis buer and twice in PBS containing 100 mM Na 3 VO 4 and then analysed by SDS ± PAGE and immunoblotting as described above.
MAP kinase assay
After treatment of cells with 100 ng/ml PDGF-BB for 5 min at 378C, the cells were lysed in lysis buer and subjected to immunoprecipitation using an anti-Erk 2 rabbit antiserum raised against a carboxyl-terminal Erk2 kinase peptide (EETARFQPGYRS). The immune complexes were washed three times with lysis buer and twice with kinase buer (20 mM HEPES pH 7.5, 10 mM MgCl 2 , 2 mM MnCl 2 , 100 mM Na 3 VO 4 and 1 mM DTT) and then incubated for 15 min at 308C in 25 ml kinase buer containing 10 mg myelin basic protein (MBP, Sigma), 1 mM protein kinase inhibitor (PKI, Sigma) and 5 mCi [g-32 P]ATP (Amersham). The kinase reaction was terminated by addition of 40 ml of 8% SDS, 0.4 M Tris-HCl pH 8.8, 1 M sucrose, 10 mM EDTA, 0.02% bromophenol blue and 4% b-mercaptoethanol and the samples were boiled for 5 min and resolved by SDS ± PAGE in a 15% SDS-polyacrylamide gel. After ®xation in methanol/acetic acid, the gel was dried and analysed by autoradiography. For quanti®cation of radioactivity, a BioImaging analyser BAS2000 (Fujix) was used.
Inositol phosphate turnover assay
Cells in 12-well dishes were incubated with myo[ 3 H]inositol in inositol-free Ham's F12 medium containing 0.3% FBS for 24 h. Lithium chloride was added to a ®nal concentration of 20 mM and incubation continued for 15 min at 378C. Cells were then treated with or without PDGF-BB (100 ng/ml) for 10 min at 378C. After washing once with ice-cold PBS, 2 ml of acidi®ed ice-cold methanol (methanol/HCl, 100 : 1 v/v) was added to each well. After incubation for 15 min on ice, the quenched samples were collected and the dishes rinsed with an additional ml of acidi®ed ice-cold methanol. To each sample 1.5 ml of water and 3 ml of chloroform was added. The tubes were mixed vigorously, and centrifuged for 5 min at low speed. The water-soluble phase was collected and diluted with two volumes of water, centrifuged for 5 min, and the upper phase applied to columns of 0.5 ml AG1-X8 (formate form, 100 ± 200 mesh; BioRad). Samples were washed with 5 mM sodium tetraborate, 60 mM sodium formate and then eluted with 5 ml of 0.1 M formic acid, 1.0 M ammonium formate and subjected to liquid scintillation counting.
Assay for release of arachidonic acid
Cells in 12-well dishes were incubated with [ 3 H]arachidonic acid (0.5 mCi/dish) in serum-free Ham's F12 medium containing 0.3% fatty-acid free BSA at 378C for 24 h. The labelled cells were rinsed four times with serum-free medium and then treated with or without PDGF-BB (50 ng/ml) for 20 min at 378C. The reaction was terminated by collecting the medium, and radioactivity in the medium was determined by liquid scintillation counting.
In vivo [
32 P]orthophosphate labelling of cells and phosphoamino acid analysis Con¯uent cells, grown in 75 cm 2 tissue culture¯asks, were starved for 24 h in serum-free Ham's F-12 medium. Cells were washed with phosphate-free Ham's F12 medium containing 0.2% dialysed FBS, and 20 mM HEPES, pH 7.2, before addition of [ 32 P]orthophosphate (1 mCi/ml; Amersham) in phosphate-free medium. Cells were then incubated for 3 h at 378C before stimulation with PDGF-BB (100 ng/ml) for 8 min at 378C. After stimulation, the cells were washed three times in ice-cold PBS before lysis in a buer containing 1% Triton X-100, 20 mM HEPES, pH 7.4, 10% glycerol, 150 mM NaCl, 10 mM MgCl 2 , 10 mM EGTA, 30 mM Na 4 P 2 O 7 , 1% Aprotinin, 1 mM PMSF, 50 mM NaF and 500 mM Na 3 V0 4 . Immunoprecipitation was performed using the anti-receptor antibody: the samples were separated by SDS ± PAGE and then transferred onto nitrocellulose membrane. For in situ tryptic digestion, the radioactively labelled aR/FR wild type and Y766F mutant receptors were cut out from the gel after exposure to ®lm, and incubated with 0.5% polyvinylpyrrolidone-40, 0.6% acetic acid for 30 min at 378C.
The ®lter pieces were rinsed three times with water and then incubated for 12 h at 378C with 400 ml of 50 mM ammonium bicarbonate containing 1 mg of modi®ed sequencing grade trypsin (Promega Corporation). The supernatants were lyophilized, oxidized in performic acid for 1 h on ice, lyophilized again, resuspended in 50 ml ammonium bicarbonate, and incubated with 1 mg trypsin for another 12 h at 378C. The samples were lyophilized, dissolved in 50 mM ammonium bicarbonate and incubated for 2 h at 48C with an antiserum raised against a synthetic peptide corresponding to amino acid residues 757 ± 784 of the FGF receptor, covalently coupled to protein A Sepharose. The immunoprecipitates were washed with 50 mM ammonium bicarbonate, 0.05% Triton X-100, twice with 150 mM ammonium bicarbonate, 0.5% Triton X-100, twice with distilled water and eluted with 1% dietylamine (pH 11.9). The peptides were then hydrolyzed in 6 M hydrochloric acid for 1 h at 1108C, separated by two-dimensional electrophoresis on a cellulose plate and then examined by autoradiography.
